Picture of Truscreen logo

TRU Truscreen Share Price

0.000.00%
nz flag iconLast trade - 00:00
HealthcareAdventurousMicro CapSucker Stock

Momentum

Relative Strength (%)
1m-4.33%
3m-19.45%
6m-29.54%
1yr-35.09%
Volume Change (%)
10d/3m+31.29%
Price vs... (%)
52w High-47.22%
50d MA-11.42%
200d MA-18.5%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-204.83%
Return on Equity-144.54%
Operating Margin-133.08%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Mar 202431st Mar 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Truscreen EPS forecast chart

Profile Summary

Truscreen Group Limited is a New Zealand-based medical device company. The Company is engaged in the development of an artificial intelligence (AI)-enabled device that can detect precancerous and cancerous cervical changes in real-time via optical and electrical measurements of cervical tissue. The Company’s cervical screening technology resolves ongoing issues with cytology, including failed samples, poor patient follow-up, patient discomfort, and the need for supporting laboratory infrastructure. The TruScreen device uses opto-electrical technology to evaluate the tissue of the cervix. The TruScreen device consists of a disposable Single Use Sensor (SUS), a Handheld Device (HHD), and an Intelligent Cradle (IC) which works together to detect and identify cancerous and precancerous changes to the cervix. It also resolves the problems associated with human papillomavirus (HPV) testing, which tests for the much more prevalent HPV virus.

Directors

    Last Annual
    March 31st, 2023
    Last Interim
    September 30th, 2023
    Incorporated
    August 9th, 2013
    Public Since
    November 12th, 2014
    Sector
    Healthcare Equipment & Supplies
    Industry
    Healthcare
    Exchange
    nz flag iconNew Zealand Stock Exchange
    Shares in Issue
    552,591,116

    TRU Share Price Performance

    Upcoming Events for TRU

    Full Year 2024 Truscreen Group Ltd Earnings Release

    Truscreen Group Ltd Annual Shareholders Meeting

    Similar to TRU

    Picture of Fisher & Paykel Healthcare logo

    Fisher & Paykel Healthcare

    nz flag iconNew Zealand Stock Exchange

    FAQ